ArticleHaematologica2021

Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells.

Brandon Cieniewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.